Healthcare -
Biotechnology - NASDAQ - US
$ 4.125
-2.6 %
$ 1.35 B
Market Cap
-3.22
P/E
IOVA - COST OF REVENUE
Cost of Revenue IOVA - Iovance Biotherapeutics, Inc.
10.8 M
LAST VALUE
-12.29%
2 YEAR CAGR
62.27%
5 YEAR CAGR
8.73%
10 YEAR CAGR